SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : 50% Gains Investing

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Steeliejim who wrote (4479)4/18/1999 3:20:00 AM
From: Dale BakerRead Replies (1) of 118717
 
ANIK - if I understand the story they blew their FDA clinical trial, got whacked, changed top management and started buying back stock. Now they have a pristine balance sheet and growing sales in Europe plus a new chance for FDA approval after the trial starting this month.

How long will the new trial take? I know nothing about the science but the downside from here seems to be almost nothing, given their cash, sales and book value.

Nice pick. I may get in soon to broaden my biotech exposure.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext